Your first Shockwave IVL newsletter, PulsePoint, has arrived. We’re kicking off with an ambitious recap of 2020, celebrating key milestones and major events for our customers using our peripheral technology across the globe. Released on a quarterly basis moving forward, PulsePoint will be the one stop shop for all the latest news and updates throughout the year. We hope you enjoy our first global edition of PulsePoint.
Read More
Topics:
Peripheral IVL,
Peripheral Cases,
PulsePoint Newsletter
The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with sub-optimal procedural outcomes, resulting in early recoil, and may contribute to restenosis.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Cases,
PAD Applications - BTK,
PAD Applications - CLI,
Peripheral Clinical Data
Following the excitement of the PAD III RCT results presented at VIVA in November, a rock star faculty of Prof. Gunnar Tepe, Prof. Thomas Zeller, Dr. Arne Schwindt and Dr. Lorenzo Patrone assembled for an incathlab session to discuss the study results and how IVL offers superior vessel preparation over conventional PTA in severely calcified PAD lesions.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data
At the recent PCR Valves eCourse (aka London Valves), an esteemed faculty reported on the use of IVL- facilitated TAVI. Profs./Drs. Carlo Di Mario, Ole De Backer, Joachim Schofer, Constantin von zur Mühlen used published data and case experiences to illustrate the advantages of using IVL to maintain transfemoral access in TAVI patients with severely calcified iliacs. Considering the importance of reducing complications to minimize hospital stay, the faculty expressed enthusiasm when considering the use of IVL in these very complex patients. Happy viewing!
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data
In life, and when treating patients, we all prefer things to be less complicated. Unfortunately, treating peripheral vascular calcification is typically associated with suboptimal vessel expansion and an increased risk of complications.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data
In DISRUPT PAD III, we included the complex, torturous, calcified lesions and risky patients that other studies avoid. Review the results for yourself and see what superior looks like.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data
Dr. Nathan Aranson is a vascular surgeon at Maine Medical Center in Portland, Maine. He shares with us his experience using IVL for aortoiliac occlusive disease (AIOD).
Read More
Topics:
Peripheral IVL,
PAD Applications - Iliac
Iliac artery calcium is particularly difficult to manage both safely and effectively with most endovascular tools and often requires costly and risky adjunctive procedures or surgical intervention, increasing morbidity and cost.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data
The COVID-19 pandemic has brought a significant focus on important clinical and economic factors such as hospital length-of-stay and hospital resource utilization. Hospitals have been forced to innovate in order to maximize the availability of these resources while treating critical patients.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
PAD Applications - TAVR Access,
PAD Applications - BTK,
PAD Applications - CLI,
Peripheral Clinical Data,
PAD Applications - EVAR
Intravascular Lithotripsy (IVL) has been used and studied across all peripheral vessels, with multiple published studies in CFA, SFA, Popliteal and Infrapopliteal arteries.
Read More
Topics:
Peripheral IVL,
DISRUPT PAD,
Peripheral Clinical Data